Present status of the detection of antifungal resistance:: the perspective from both sides of the ocean

被引:22
作者
Cuenca-Estrella, M [1 ]
Rodríguez-Tudela, JL [1 ]
机构
[1] Inst Salud Carlos III, Ctr Nacl Microbiol, Serv Micol, Madrid 28220, Spain
关键词
D O I
10.1111/j.1469-0691.2001.tb00009.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The NCCLS reference methodology for antifungal susceptibility testing is a new milestone of the evolution of medical mycology. The use of this methodology however, is not problem-free. At present, major limitations are a trailing phenomenon with azoles. unreliable detection of resistance to amphotericin B, poor growth of some organisms and unpractical procedures for the clinical laboratory. Herein a overview of NCCLS guidelines for yeasts and filamentous fungi is presented. Likewise. a review of studies conducted trying to overcome the limitations of reference procedures is also included. Several alternative approaches are reviewed as alternative media. inoculum size and incubation time. Modifications of reading procedure and endpoint determination are also evaluated. Agar diffusion methods and other methods for susceptibility testing are cited. Finally, we discuss the data on correlation of the in vitro results with the in vivo activity.
引用
收藏
页码:46 / 53
页数:8
相关论文
共 65 条
[1]   CORRELATION BETWEEN IN-VITRO AND IN-VIVO ACTIVITY OF ANTIFUNGAL AGENTS AGAINST CANDIDA SPECIES [J].
ANAISSIE, EJ ;
KARYOTAKIS, NC ;
HACHEM, R ;
DIGNANI, MC ;
REX, JH ;
PAETZNICK, V .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (02) :384-389
[2]   Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invasive candidiasis [J].
Arthington-Skaggs, BA ;
Warnock, DW ;
Morrison, CJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (08) :2081-2085
[3]  
Arthington-Skaggs BA, 2000, J CLIN MICROBIOL, V38, P2254
[4]   COMPARATIVE-STUDY OF BROTH MACRODILUTION AND MICRODILUTION TECHNIQUES FOR IN-VITRO ANTIFUNGAL SUSCEPTIBILITY TESTING OF YEASTS BY USING THE NATIONAL-COMMITTEE-FOR-CLINICAL-LABORATORY-STANDARDS PROPOSED STANDARD [J].
BARCHIESI, F ;
COLOMBO, AL ;
MCGOUGH, DA ;
RINALDI, MG .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (10) :2494-2500
[5]   Fluconazole disk diffusion procedure for determining susceptibility of Candida species [J].
Barry, AL ;
Brown, SD .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (09) :2154-2157
[6]  
Cantón E, 1999, J CLIN MICROBIOL, V37, P2197
[7]   Correlation between in vitro susceptibility determined by E test and response to therapy with amphotericin B: Results from a multicenter prospective study of candidemia [J].
Clancy, CJ ;
Nguyen, MH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (05) :1289-1290
[8]   Comparative in vitro activity of voriconazole and itraconazole against fluconazole-susceptible and fluconazole-resistant clinical isolates of Candida species from Spain [J].
Cuenca-Estrella, M ;
Díaz-Guerra, TM ;
Mellado, E ;
Monzón, A ;
Rodríguez-Tudela, JL .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1999, 18 (06) :432-435
[9]   Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus [J].
Cuenca-Estrella, M ;
Rodríguez-Tudela, JL ;
Mellado, E ;
Martínez-Suárez, JV ;
Monzón, A .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (04) :531-533
[10]   Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum [J].
Cuenca-Estrella, M ;
Ruiz-Díez, B ;
Martínez-Suárez, JV ;
Monzón, A ;
Rodríguez-Tudela, JL .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (01) :149-151